Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -143,003 | -75,971 | -180,091 | -128,518 | -92,879 |
| Depreciation Amortization | 16,095 | 7,092 | 25,996 | 28,923 | 18,216 |
| Accounts receivable | -777 | 1,241 | 853 | 2,577 | 4,056 |
| Accounts payable and accrued liabilities | -2,917 | -4,606 | 2,467 | -4,325 | -632 |
| Other Working Capital | -5,212 | -11,322 | 80,775 | 64,805 | 28,799 |
| Other Operating Activity | 43,688 | 28,246 | 55,208 | 48,623 | 22,462 |
| Operating Cash Flow | $-92,126 | $-55,320 | $-14,792 | $12,085 | $-19,978 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,796 | 38,432 | -113,472 | -126,042 | -163,936 |
| PPE Investments | N/A | -131 | -5,101 | -4,947 | -4,598 |
| Purchase Sale Intangibles | -16,579 | -5,136 | -19,050 | -14,004 | -8,979 |
| Other Investing Activity | -16,727 | -5,136 | -19,050 | -14,004 | -8,979 |
| Investing Cash Flow | $-5,931 | $33,165 | $-137,623 | $-144,993 | $-177,513 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 104,926 | 104,926 | N/A | N/A | N/A |
| Common Stock Issued | 20,492 | 19,667 | 237,775 | 200,835 | 197,230 |
| Other Financing Activity | -10,674 | -10,680 | -6,092 | -2,365 | -1,174 |
| Financing Cash Flow | $114,744 | $113,913 | $231,683 | $198,470 | $196,056 |
| Exchange Rate Effect | -2,681 | -939 | 1,713 | -7 | -49 |
| Beginning Cash Position | 165,753 | 165,753 | 84,772 | 84,772 | 84,772 |
| End Cash Position | 179,759 | 256,572 | 165,753 | 150,327 | 83,288 |
| Net Cash Flow | $14,006 | $90,819 | $80,981 | $65,555 | $-1,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -92,126 | -55,320 | -14,792 | 12,085 | -19,978 |
| Capital Expenditure | N/A | -131 | -5,101 | -4,947 | -4,598 |
| Free Cash Flow | -92,126 | -55,451 | -19,893 | 7,138 | -24,576 |